02.26.14
The U.S. Food and Drug Administration has given Solana Surgical LLC clearance to market its CrossCHECKPlating System for foot and ankle procedures.
Solana claims its CrossCHECK System plates are manufactured with a Type II anodization, which enhances the fatigue strength of the device, and thus improves stabilization. In addition, specially designed ridges are built into the plates to enhance grip, and act as a buttress during the compression process.
“Studies have shown that similar ridges can also improve host bone health,” said Rebecca Wahl, Solana's vice president of Research and Development.
Solana Surgical is a global extremity orthopedic company that develops motion restoration and pain relief solutions. The Memphis, Tenn.-based company launched its first product in 2011.
The first phase of commercialization will include plates that will primarily be used for stabilization and fixation (leading to fusion) in the forefoot and mid-foot. Fusion often is the preferred procedure to relieve pain and correct skeletal alignment issues in patients with arthritis, as well as small joint fractures and bunions.
Solana claims its CrossCHECK System plates are manufactured with a Type II anodization, which enhances the fatigue strength of the device, and thus improves stabilization. In addition, specially designed ridges are built into the plates to enhance grip, and act as a buttress during the compression process.
“Studies have shown that similar ridges can also improve host bone health,” said Rebecca Wahl, Solana's vice president of Research and Development.
The CrossCHECK Plating System offers various sizes and configurations for specific surgical needs. The company intends to roll out the product in the first quarter this year.
Solana Surgical is a global extremity orthopedic company that develops motion restoration and pain relief solutions. The Memphis, Tenn.-based company launched its first product in 2011.